NOVARTIS popularity and NOVARTIS trends

Drug firm Novartis India said its net profit declined by 3.23% to Rs 32.9 crore for the fourth quarter ended March 31, 2012.

ZURICH (Reuters) - A Novartis experimental lung drug to treat smokers' cough was superior to a placebo in improving lung function over a one-year period and had similar efficacy to a rival drug from Pfizer and Boehringer Ingelheim, the Swiss drugmaker said on Thursday.

Continuous manufacturing will transform the drugs are made, says Novartis president. At the second day of a manufacturing conference on MIT’s campus, the CEO of pharmaceutical giant Novartis, Joseph Jimenez, suggested big changes are in store for the way his company makes drugs. A new, experimental method for producing pills could drastically reduce production times, increase revenue, and impro...

The maker's of a drug that treats age-related macular degeneration, a disease that can cause loss of sight, are taking the NHS to court to block them from using a drug that costs ten times less and is just as effective, according to tests.

Der Schweizer Leitindex ist in den vergangenen Jahren steil gestiegen. Die Dickschiffe Nestlé, Novartis und Roche tragen einen großen Teil dazu bei - für die Fondsmanager ist ihre Dominanz aber ein Problem.

Zürich (ots) - ~ - Querverweis: Das Ranking und die Markenprofile liegen in der digitalen Pressemappe zum Download vor und sind unter http://www.presseportal.de/dokumente abrufbar - ~ Nescafé führt vor Roche und Novartis die Rangliste der 50 wertvollsten Schweizer Marken an. Zu diesem …

Der Schweizer Pharmakonzern Novartis kauft für 1,5 Milliarden Dollar die amerikanische Generikfirma Fougera. Damit wird der Branchen-Zweite der führende Anbieter von dermatologischen Generikprodukten.

May 03 - Fitch Ratings says the big Fitch-rated European pharmaceuticals companies, such as Novartis (rated 'AA'), have headroom within their current ratings to pursue bolt-on or even larger...

Swiss drugmaker Novartis has sealed a deal to buy Fougera Pharmaceuticals, a maker of generic dermatology products, for $1.53bn in cash.

SWISS DRUGMAKER Novartis has stuck to its outlook for lower profitability this year, as a stoppage at a US manufacturing site and tough annual comparisons for its Sandoz division hit first-quarter core earnings.

Novartis is taking legal action in Britain to make state-run hospitals use an eye drug that costs about 700 pounds ($1,130) per shot.

LONDON (AP) -- Drug maker Novartis says it is taking legal action in Britain to make hospitals use an eye drug that costs 700 pounds ($1,130) per shot instead of a cheaper one that costs 60 pounds ($97)....

Long-term pressures on health budgets exacerbated by short-term difficulties at Swiss pharma’s subsidiaries

Die Investoren würden Novartis "zu wenig Respekt" zollen, befand das renommierte Anlegermagazin "Barron's" vor kurzem. Doch die Zurückhaltung der Anleger scheint im Nachhinein gut begründet.

Swiss drugmaker Novartis reports a sharp fall in profits, due in part to manufacturing problems at a US plant and to currency moves.

The pharmaceutical company Novartis is challenging the use of a cheaper alternative to its drug Lucentis for a common cause of loss of vision.

European regulators have endorsed the continued use of Novartis's multiple sclerosis pill Gilenya, one of the Swiss firm's top new drug hopes, but said today the drug needed to carry stronger warnings on heart risks.

He IS just way too cool! Yesterday, we speculated on WHY Kanye West suddenly changed the name of his recent single Theraflu to Way Too Cold over the weekend, thinking pressure from the medicine company forced 'Ye's hand. NOPE! In fact, Novartis - the people behind Theraflu - didn't give two ships about the homage [...]

Top court ruling on dispute between pharma giant Novartis and government will have major impact on country’s booming generic industry

Top court ruling on dispute between pharma giant Novartis and government will have major impact on country’s booming generic industry

Pharmaceutical maker Novartis doesn't get much respect from investors. But there are lots of reasons why it should, including bright prospects and a fat dividend.

(Reuters) - United Therapeutics Corp said it filed a lawsuit against Novartis AG's generic unit Sandoz, alleging infringement of the biotechnology company's patent on its pulmonary hypertension drug.

Le laboratoire pharmaceutique américain Pfizer, qui cherche à se séparer...

Novartis met en danger les traitements à bas prix en se battant en justice pour imposer un brevet.

El acuerdo de libre comercio limitaría los genéricos que abastecen al 90% de personas con VIH. El pleito de Novartis por una patente simboliza el conflicto y moviliza a las ONG

[[368713]] ZURICH (Suisse) (AFP) : Le groupe pharmaceutique suisse Novartis a obtenu de l'Union européenne le feu vert pour l'extension de son traitement avec le médicament Glivec de certaines formes rares du cancer gastro-intestinal, a-t-il annoncé lundi. La Commission européenne a homologué...

En la India, los medicamentos genéricos representan el 80 por ciento de las medicinas utilizadas por la ONG Médicos Sin Fronteras, la cual trata a 170 mil personas en 19 países

Pharmaceutical giant Novartis has recalled the painkiller Excedrin in South Africa.

DAVOS, Switzerland—CEO Joe Jimenez is confident Novartis AG (NVS) will be able to quickly mitigate the drop in revenue from patent expirations with help from a pipeline of potential blockbuster drugs already on the market. The Swiss drug maker’s shares skidded more than 2% Wednesday amid concerns about its outlook, complicated by patent expiration for [...]

Novartis AG anunció el viernes que suprimirá 1.960 puestos de trabajo como resultado de la reestructuración de su negocio estadounidense, lo que refleja la pérdida de la patente de su fármaco Diovan en EE.UU. y el reciente fracaso en su intento por convertir su preparado para la hipertensión Rasilez en un medicamento estrella.

The news the butter and sugar industries didn't want to believe was coming but knew was coming has finally came in a swarm of flying Truvia packets. After months of rumors, our butter messiah Paula Deen is about to announce that she's been diagnosed with Type 2 diabetes. That sound you hear is butter-thirsty Norwegians diving into the butter lake in the underground cavern under Paula's h...

C'est la perte d'un important brevet qui vient à expiration, et l'échec enregistré sur plusieurs médicaments qui ont conduit le groupe pharmaceutique…

The Swiss drugmaker Novartis is cutting nearly 2,000 jobs in the United States, anticipating the impending loss of patent protection on its blockbuster drug Diovan.

Le laboratoire suisse s'adapte en particulier à l'extinction du brevet qui protège son médicament vedette Diovan contre l'hypertension artérielle.

Swiss drugmaker Novartis has announced plans to cut 1,960 jobs in the US ahead of the loss of its patent on blood pressure drug Diovan.

GENEVA (AP) -- Swiss pharmaceutical company Novartis AG says it is cutting 1,960 jobs in the United States this year....

The US Food and Drug Administration is warning patients about a potential mix-up between powerful prescription pain drugs and common over-the-counter medications made at a Novartis manufacturing plant.

WASHINGTON — The Food and Drug Administration is warning patients about a potential mix-up between powerful prescription pain drugs and common over-the-counter medications made at a Novartis manufacturing plant. The issue stems from manufacturing problems at a Lincoln, Neb., facility which triggered a recall Sunday of 1,645 lots of Novartis’ over-the-counter drugs, including Excedrin, Bufferin,...

Certain packages of Excedrin, NoDoz, Bufferin and Gas-X Prevention are being voluntarily recalled by Novartis Consumer Health because the bottles may contain stray pills of other medicines, or broken or chipped pills. The Food and Drug Administration announced the recall affects Excedrin and NoDoz medicines with expiration dates of Dec. 20, 2014 or earlier and Bufferin and Gas-X Prevention medi...

Novartis recalls some bottles of Excedrin, NoDoz, Bufferin and Gas-X over concerns that they could contain stray pills or chipped tablets.

Pharmaceutical company Novartis on Sunday voluntarily recalled a number of over-the-counter drugs -- including certain bottles of Excedrin and Bufferin -- due to complaints about mislabeled and broken pills.

Der Stuttgarter Pharmahändler Celesio hat sich mit dem Schweizer Arzneimittelhersteller Novartis im Streit um neue Lieferkonditionen geeinigt. Seit 15. Oktober wurde eine Tochterfirma nicht mehr von Novartis beliefert.

Clinical trials of the treatments, from Novartis and Genentech, showed they could lengthen lives.

Drug giant redirects psychiatric efforts to genetics.